Zhitong Finance App News, Fosun Pharmaceutical (02196.HK) announced that in order to focus on unmet clinical needs, further enrich the Group's innovative product pipeline matrix in the field of central nervous system treatment, improve the market layout, and create integrated diagnosis and treatment solutions with multiple technology path collaboration, the holding subsidiary Fosun Pharmaceutical will invest a total of 141,24816.33 million yuan to invest in Green Valley Pharmaceuticals, including:

Zhitong Finance App News, Fosun Pharmaceutical (02196.HK) announced that in order to focus on unmet clinical needs, further enrich the Group's innovative product pipeline matrix in the field of central nervous system treatment, improve the market layout, and create integrated diagnosis and treatment solutions with multiple technology path collaboration, the holding subsidiary Fosun Pharmaceutical will invest a total of 141,24816.33 million yuan to invest in Green Valley Pharmaceuticals, including: